Clinical and Pathological Characteristics of High Grade Colorectal Adenocarcinoma at Hasanuddin University Hospital, Indonesia, 2015-2020
AbstractColorectal cancer is one of the most common cancers and the fourth leading cause of cancer-related death in the world. According to the type of histopathology, more than 90% of colorectal carcinomas are adenocarcinomas which are grouped into low grade and high grade based on their grading. Identification of characteristic groupings based on grading is still rarely done in Indonesia, especially in Makassar. This study aims to determine the clinical and pathological characteristics of high grade colorectal adenocarcinoma at Hasanuddin University Hospital, Makassar from January 2015 to December 2020. This study used a descriptive method. The sample used was a sample that was diagnosed histopathologically as high grade colorectal adenocarcinoma and met the inclusion criteria then selected by total sampling and also used data from medical records. The distribution of data in this study is classified based on age, gender, tumor location, clinical symptoms, and tumor stage. Descriptive statistical calculations were performed using SPSS 20 for Windows software. There were 98 samples, most of which were at the age of ≥50 years, as many as 32 samples (32.7%) with man as many as 60 samples (61.2%). The most common location was in the rectum as many as 38 samples (38.8%) with the most clinical symptoms were bowel disorders as many as 68 samples (69.4%) and stage 3 was the most cases with 35 samples (35.7%).
I. Yusuf et al., “Genetic risk factors for colorectal cancer in multiethnic Indonesians,” Sci. Rep., vol. 11, no. 1, pp. 1–9, 2021, doi: 10.1038/s41598-021-88805-4.
M. Arnold, M. S. Sierra, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray, “Global patterns and trends in colorectal cancer incidence and mortality,” Gut, vol. 66, no. 4, pp. 683–691, 2017, doi: 10.1136/gutjnl-2015-310912.
N. Hamzah, S. Wahid, N. Ketut Sungowati, M. Husni Cangara, A. Alfian Zainuddin, and U. Anderiani Miskad, “Tumour-Infiltrating Lymphocytes in Colorectal Adenocarcinoma,” Int. J. Sci. Basic Appl. Res. Int. J. Sci. Basic Appl. Res., vol. 47, no. 2, pp. 68–76, 2019, [Online]. Available: http://gssrr.org/index.php?journal=JournalOfBasicAndApplied.
R. L. Siegel et al., “Colorectal cancer statistics, 2020,” CA: A Cancer Journal for Clinicians, vol. 70, no. 3. pp. 145–164, 2020, doi: 10.3322/caac.21601.
U. A. MISKAD, N. HAMZAH, M. H. CANGARA, B. J. NELWAN, R. MASADAH, and S. WAHID, “Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in colorectal adenocarcinoma,” Minerva Med., vol. 111, no. 4, pp. 337–343, 2020, doi: 10.23736/S0026-4806.20.06401-0.
The Global Cancer Observatory, “Cancer Incident in Indonesia,” Int. Agency Res. Cancer, vol. 858, pp. 1–2, 2020.
Kemenkes RI, “Panduan Penatalaksanaan Kanker kolorektal,” Kementeri. Kesehat. Republik Indones., p. 76, 2016.
J. Paulus, “Colorectal Cancer Facts and Figures 2020-2022,” Am. cancer Soc., vol. 66, no. 11, pp. 1–9, 2020.
M. Fleming, S. Ravula, S. F. Tatishchev, and H. L. Wang, “Colorectal carcinoma: Pathologic aspects,” Journal of Gastrointestinal Oncology, vol. 3, no. 3. pp. 153–173, 2012, doi: 10.3978/j.issn.2078-6891.2012.030.
W. L. Neuman and R. M. Genta, Cancer Grading Manual, 2nd ed. New York: Springer US, 2013.
M. Y. Lubis, M. Abdullah, I. Hasan, and S. Suwarto, “Probabilitas Temuan Kanker Kolorektal pada Pasien Simtomatik Berdasarkan Unsur-Unsur Asia Pacific Colorectal Screening (APCS),” J. Penyakit Dalam Indones., vol. 2, no. 2, p. 90, 2017, doi: 10.7454/jpdi.v2i2.71.
S.-T. M. Nagtegaal ID, Arends MJ, “Colorectal adenocarcinoma,” in WHO Classification of Tumours. Digestive System Tumours, 5th ed., O. R. L.Nagtegaal ID., Arends MJ., Ed. Lyon, 2019, pp. 177–87.
M. Wahidin, R. Noviani, S. Hermawan, V. Andriani, A. Ardian, and H. Djarir, “Population-based cancer registration in indonesia,” Asian Pacific J. Cancer Prev., vol. 13, no. 4, pp. 1709–1710, 2012, doi: 10.7314/APJCP.2012.13.4.1709.
F. T. Kolligs, “Diagnostics and epidemiology of colorectal cancer,” Visc. Med., vol. 32, no. 3, pp. 158–164, 2016, doi: 10.1159/000446488.
O. Purim, N. Gordon, and B. Brenner, “Cancer of the colon and rectum: Potential effects of sex-age interactions on incidence and outcome,” Med. Sci. Monit., vol. 19, no. 1, pp. 203–209, 2013, doi: 10.12659/MSM.883842.
J. H. Lin et al., “Association between sex hormones and colorectal cancer risk in men and women,” Clin. Gastroenterol. Hepatol., vol. 11, no. 4, pp. 419–424, 2013, doi: 10.1016/j.cgh.2012.11.012.
M. S. Padang and L. Rotty, “Adenokarsinoma Kolon: Laporan Kasus,” e-CliniC, vol. 8, no. 2, pp. 229–236, 2020, doi: 10.35790/ecl.v8i2.30539.
T. A. R. Amber Cockburn, “Gastrointestinal Neuroendocrine Lesions,” in Fenoglio-Preiser’s Gastrointestinal Pathology, 4th ed., A. Noffsinger, Ed. Philadelphia: Wolters Kluwer, 2017, pp. 3354–3433.
O. Majek et al., “Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany,” PLoS ONE, vol. 8, no. 7. 2013, doi: 10.1371/journal.pone.0068077.
S. Sebastian, “Management of colorectal cancer,” F1000Prime Rep., vol. 6, p. 108, 2014, doi: 10.12703/P6-108.
A. B. Benson, Ed., “Treatmen Update: Colorectal,” in Cancercare Connect Booklet series, New York: Cancercare, 2021, pp. 1–24.
Copyright (c) 2021 International Journal of Sciences: Basic and Applied Research (IJSBAR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who submit papers with this journal agree to the following terms.